Tanzania

Tanzania

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.54 (3.43 - 3.66) 2019 Modelled IHME
3.63 (3.53 - 3.74) 2018 Modelled IHME
3.77 (3.66 - 3.89) 2017 Modelled IHME
3.99 (3.87 - 4.11) 2016 Modelled IHME
4.22 (4.10 - 4.37) 2015 Modelled IHME
4.39 (4.26 - 4.54) 2014 Modelled IHME
4.52 (4.40 - 4.68) 2013 Modelled IHME
4.65 (4.52 - 4.81) 2012 Modelled IHME
4.78 (4.64 - 4.95) 2011 Modelled IHME
4.92 (4.77 - 5.11) 2010 Modelled IHME
5.09 (4.93 - 5.27) 2009 Modelled IHME
5.27 (5.11 - 5.45) 2008 Modelled IHME
5.45 (5.28 - 5.65) 2007 Modelled IHME
5.63 (5.45 - 5.86) 2006 Modelled IHME
5.8 (5.60 - 6.05) 2005 Modelled IHME
5.97 (5.76 - 6.23) 2004 Modelled IHME
6.15 (5.92 - 6.42) 2003 Modelled IHME
6.32 (6.08 - 6.60) 2002 Modelled IHME
6.47 (6.22 - 6.77) 2001 Modelled IHME
6.57 (6.30 - 6.91) 2000 Modelled IHME
6.64 (6.37 - 6.98) 1999 Modelled IHME
6.69 (6.43 - 7.04) 1998 Modelled IHME
6.74 (6.47 - 7.09) 1997 Modelled IHME
6.78 (6.50 - 7.15) 1996 Modelled IHME
6.83 (6.53 - 7.22) 1995 Modelled IHME
6.88 (6.59 - 7.25) 1994 Modelled IHME
6.93 (6.66 - 7.31) 1993 Modelled IHME
6.98 (6.71 - 7.36) 1992 Modelled IHME
7.03 (6.74 - 7.42) 1991 Modelled IHME
7.08 (6.78 - 7.47) 1990 Modelled IHME
3.5 (2.10 - 5) 2017 Survey/reported Tanzania HIV Impact Survey (THIS) 2016-2017, 2018
4.03 (3.06 - 5.16) 2015 Modelled WHO
7.17 (6.59 - 7.79) 2013 Modelled Schweitzer et al, 2015
4.1 (3.20 - 5.40) 2016 Modelled Razavi-Shearer et al, 2018
7.17 (6.59 - 7.79) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.38 (0.31 - 0.45) 2019 Modelled IHME
0.41 (0.34 - 0.50) 2018 Modelled IHME
0.44 (0.36 - 0.55) 2017 Modelled IHME
0.47 (0.39 - 0.56) 2016 Modelled IHME
0.49 (0.40 - 0.59) 2015 Modelled IHME
0.5 (0.42 - 0.60) 2014 Modelled IHME
0.51 (0.43 - 0.60) 2013 Modelled IHME
0.52 (0.43 - 0.62) 2012 Modelled IHME
0.53 (0.44 - 0.64) 2011 Modelled IHME
0.55 (0.45 - 0.66) 2010 Modelled IHME
0.59 (0.49 - 0.71) 2009 Modelled IHME
0.67 (0.55 - 0.80) 2008 Modelled IHME
0.77 (0.64 - 0.92) 2007 Modelled IHME
0.9 (0.76 - 1.07) 2006 Modelled IHME
1.06 (0.88 - 1.27) 2005 Modelled IHME
1.43 (1.20 - 1.71) 2004 Modelled IHME
2.06 (1.73 - 2.47) 2003 Modelled IHME
2.77 (2.33 - 3.33) 2002 Modelled IHME
3.36 (2.81 - 4.09) 2001 Modelled IHME
3.66 (3.02 - 4.50) 2000 Modelled IHME
3.73 (3.08 - 4.62) 1999 Modelled IHME
3.78 (3.11 - 4.75) 1998 Modelled IHME
3.82 (3.11 - 4.80) 1997 Modelled IHME
3.85 (3.11 - 4.85) 1996 Modelled IHME
3.88 (3.10 - 4.92) 1995 Modelled IHME
3.91 (3.15 - 4.91) 1994 Modelled IHME
3.95 (3.20 - 4.92) 1993 Modelled IHME
3.98 (3.24 - 4.92) 1992 Modelled IHME
4.01 (3.29 - 4.92) 1991 Modelled IHME
4.03 (3.31 - 4.99) 1990 Modelled IHME
1.69 (1.08 - 2.54) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,834,400 (1,755,700 - 1,934,320) 1990 Modelled IHME
1,875,780 (1,797,450 - 1,977,830) 1991 Modelled IHME
1,917,540 (1,841,610 - 2,020,150) 1992 Modelled IHME
1,959,580 (1,881,450 - 2,066,330) 1993 Modelled IHME
2,001,810 (1,917,750 - 2,109,480) 1994 Modelled IHME
2,044,120 (1,954,770 - 2,159,320) 1995 Modelled IHME
2,087,730 (2,002,010 - 2,201,390) 1996 Modelled IHME
2,132,660 (2,047,050 - 2,242,850) 1997 Modelled IHME
2,177,070 (2,089,900 - 2,290,240) 1998 Modelled IHME
2,219,050 (2,128,590 - 2,332,510) 1999 Modelled IHME
2,256,440 (2,165,380 - 2,372,240) 2000 Modelled IHME
2,281,540 (2,193,250 - 2,389,070) 2001 Modelled IHME
2,291,050 (2,201,480 - 2,391,930) 2002 Modelled IHME
2,289,450 (2,203,920 - 2,388,030) 2003 Modelled IHME
2,282,060 (2,200,920 - 2,379,680) 2004 Modelled IHME
2,274,770 (2,195,620 - 2,373,230) 2005 Modelled IHME
2,265,750 (2,192,790 - 2,357,150) 2006 Modelled IHME
2,250,820 (2,180,520 - 2,333,500) 2007 Modelled IHME
2,232,990 (2,165,520 - 2,310,660) 2008 Modelled IHME
2,215,220 (2,148,340 - 2,294,760) 2009 Modelled IHME
2,200,860 (2,133,520 - 2,283,590) 2010 Modelled IHME
2,193,940 (2,130,040 - 2,271,640) 2011 Modelled IHME
2,192,440 (2,130,440 - 2,267,600) 2012 Modelled IHME
2,190,500 (2,129,730 - 2,265,480) 2013 Modelled IHME
2,181,280 (2,116,920 - 2,256,710) 2014 Modelled IHME
2,157,060 (2,092,360 - 2,233,880) 2015 Modelled IHME
2,091,360 (2,031,910 - 2,158,540) 2016 Modelled IHME
2,027,820 (1,969,110 - 2,095,990) 2017 Modelled IHME
2,005,750 (1,951,100 - 2,066,390) 2018 Modelled IHME
2,008,560 (1,948,220 - 2,074,120) 2019 Modelled IHME
2,261,000 (1,755,000 - 3,022,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.82 (1.81 - 4.06) 2019 Modelled IHME
3.02 (1.94 - 4.31) 2018 Modelled IHME
3.1 (2.02 - 4.42) 2017 Modelled IHME
3.01 (1.96 - 4.29) 2016 Modelled IHME
2.97 (1.94 - 4.21) 2015 Modelled IHME
3.15 (2.08 - 4.41) 2014 Modelled IHME
3.51 (2.35 - 4.81) 2013 Modelled IHME
3.92 (2.70 - 5.33) 2012 Modelled IHME
4.3 (3.02 - 5.86) 2011 Modelled IHME
4.59 (3.27 - 6.11) 2010 Modelled IHME
4.73 (3.41 - 6.24) 2009 Modelled IHME
4.84 (3.54 - 6.37) 2008 Modelled IHME
4.92 (3.56 - 6.53) 2007 Modelled IHME
4.97 (3.65 - 6.53) 2006 Modelled IHME
5.04 (3.69 - 6.64) 2005 Modelled IHME
5.07 (3.71 - 6.59) 2004 Modelled IHME
5.09 (3.75 - 6.74) 2003 Modelled IHME
5.11 (3.75 - 6.76) 2002 Modelled IHME
5.22 (3.84 - 6.93) 2001 Modelled IHME
5.17 (3.73 - 6.87) 2000 Modelled IHME
5.06 (3.63 - 6.69) 1999 Modelled IHME
4.86 (3.52 - 6.49) 1998 Modelled IHME
4.9 (3.55 - 6.62) 1997 Modelled IHME
4.93 (3.57 - 6.70) 1996 Modelled IHME
4.99 (3.59 - 6.79) 1995 Modelled IHME
5.06 (3.65 - 6.90) 1994 Modelled IHME
5.12 (3.68 - 7.01) 1993 Modelled IHME
5.15 (3.67 - 7.01) 1992 Modelled IHME
5.21 (3.71 - 7.01) 1991 Modelled IHME
5.27 (3.75 - 7.15) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,602 (1,027 - 2,303) 2019 Modelled IHME
1,668 (1,072 - 2,384) 2018 Modelled IHME
1,671 (1,088 - 2,383) 2017 Modelled IHME
1,580 (1,028 - 2,249) 2016 Modelled IHME
1,520 (990 - 2,152) 2015 Modelled IHME
1,568 (1,034 - 2,196) 2014 Modelled IHME
1,702 (1,140 - 2,331) 2013 Modelled IHME
1,848 (1,272 - 2,511) 2012 Modelled IHME
1,973 (1,388 - 2,691) 2011 Modelled IHME
2,050 (1,462 - 2,729) 2010 Modelled IHME
2,058 (1,485 - 2,715) 2009 Modelled IHME
2,051 (1,503 - 2,700) 2008 Modelled IHME
2,031 (1,472 - 2,696) 2007 Modelled IHME
2,001 (1,470 - 2,628) 2006 Modelled IHME
1,977 (1,448 - 2,604) 2005 Modelled IHME
1,935 (1,416 - 2,517) 2004 Modelled IHME
1,896 (1,395 - 2,510) 2003 Modelled IHME
1,852 (1,359 - 2,450) 2002 Modelled IHME
1,840 (1,353 - 2,445) 2001 Modelled IHME
1,775 (1,281 - 2,360) 2000 Modelled IHME
1,693 (1,214 - 2,236) 1999 Modelled IHME
1,582 (1,144 - 2,110) 1998 Modelled IHME
1,552 (1,123 - 2,096) 1997 Modelled IHME
1,518 (1,099 - 2,062) 1996 Modelled IHME
1,493 (1,074 - 2,032) 1995 Modelled IHME
1,472 (1,062 - 2,008) 1994 Modelled IHME
1,446 (1,041 - 1,981) 1993 Modelled IHME
1,415 (1,007 - 1,924) 1992 Modelled IHME
1,390 (991 - 1,869) 1991 Modelled IHME
1,365 (972 - 1,852) 1990 Modelled IHME
2,750 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (19 - 33) 2019 Modelled IHME
25 (19 - 33) 2018 Modelled IHME
25 (19 - 33) 2017 Modelled IHME
25 (19 - 33) 2016 Modelled IHME
25 (19 - 32) 2015 Modelled IHME
25 (19 - 33) 2014 Modelled IHME
25 (19 - 32) 2013 Modelled IHME
25 (19 - 33) 2012 Modelled IHME
26 (20 - 33) 2011 Modelled IHME
26 (20 - 34) 2010 Modelled IHME
26 (20 - 34) 2009 Modelled IHME
26 (20 - 34) 2008 Modelled IHME
26 (19 - 33) 2007 Modelled IHME
26 (19 - 33) 2006 Modelled IHME
26 (19 - 34) 2005 Modelled IHME
26 (20 - 34) 2004 Modelled IHME
26 (20 - 34) 2003 Modelled IHME
26 (20 - 34) 2002 Modelled IHME
26 (20 - 34) 2001 Modelled IHME
26 (20 - 34) 2000 Modelled IHME
27 (20 - 34) 1999 Modelled IHME
27 (21 - 35) 1998 Modelled IHME
27 (21 - 35) 1997 Modelled IHME
27 (21 - 35) 1996 Modelled IHME
27 (21 - 35) 1995 Modelled IHME
27 (20 - 35) 1994 Modelled IHME
27 (20 - 35) 1993 Modelled IHME
26 (20 - 35) 1992 Modelled IHME
26 (20 - 34) 1991 Modelled IHME
26 (20 - 34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
91 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
90 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
85 2009 Survey/reported WHO/UNICEF
86 2008 Survey/reported WHO/UNICEF
83 2007 Survey/reported WHO/UNICEF
90 2006 Survey/reported WHO/UNICEF
90 2005 Survey/reported WHO/UNICEF
95 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
89 2002 Survey/reported WHO/UNICEF
89 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 3) 2016 Survey/reported Larney S et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
Year of HBV elimination goal
2030
HBV elimination goal
HBV testing policy
Pregnant women
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.48 (1.17 - 1.85) 2019 Modelled IHME
1.47 (1.17 - 1.84) 2018 Modelled IHME
1.47 (1.17 - 1.83) 2017 Modelled IHME
1.46 (1.18 - 1.82) 2016 Modelled IHME
1.45 (1.17 - 1.81) 2015 Modelled IHME
1.45 (1.18 - 1.81) 2014 Modelled IHME
1.45 (1.17 - 1.81) 2013 Modelled IHME
1.45 (1.17 - 1.82) 2012 Modelled IHME
1.45 (1.16 - 1.82) 2011 Modelled IHME
1.45 (1.16 - 1.82) 2010 Modelled IHME
1.45 (1.16 - 1.82) 2009 Modelled IHME
1.46 (1.17 - 1.82) 2008 Modelled IHME
1.47 (1.17 - 1.83) 2007 Modelled IHME
1.48 (1.18 - 1.84) 2006 Modelled IHME
1.48 (1.18 - 1.84) 2005 Modelled IHME
1.48 (1.19 - 1.84) 2004 Modelled IHME
1.48 (1.19 - 1.84) 2003 Modelled IHME
1.48 (1.20 - 1.83) 2002 Modelled IHME
1.48 (1.20 - 1.83) 2001 Modelled IHME
1.48 (1.20 - 1.84) 2000 Modelled IHME
1.48 (1.20 - 1.84) 1999 Modelled IHME
1.48 (1.19 - 1.84) 1998 Modelled IHME
1.47 (1.18 - 1.83) 1997 Modelled IHME
1.47 (1.18 - 1.84) 1996 Modelled IHME
1.47 (1.18 - 1.85) 1995 Modelled IHME
1.47 (1.18 - 1.84) 1994 Modelled IHME
1.47 (1.19 - 1.84) 1993 Modelled IHME
1.48 (1.19 - 1.84) 1992 Modelled IHME
1.48 (1.19 - 1.86) 1991 Modelled IHME
1.49 (1.20 - 1.87) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 2017 Survey/reported Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), 2018
2.7 (0.20 - 7.80) 2014 Modelled Riou et al, 2015
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
0.5 2017 Survey/reported Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), 2018
People who inject drugs (PWID)
Download
Value (%) Year Type Source
27.7 (22.40 - 33.50) 2011 Survey/reported Bowring AL et al, 2013
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
385,057 (309,934 - 483,453) 1990 Modelled IHME
395,001 (318,523 - 495,295) 1991 Modelled IHME
405,420 (326,424 - 506,400) 1992 Modelled IHME
416,348 (335,141 - 521,337) 1993 Modelled IHME
427,829 (344,527 - 535,980) 1994 Modelled IHME
439,906 (353,698 - 552,663) 1995 Modelled IHME
452,818 (362,618 - 567,262) 1996 Modelled IHME
466,549 (374,390 - 580,402) 1997 Modelled IHME
480,775 (387,006 - 599,046) 1998 Modelled IHME
495,168 (400,113 - 614,793) 1999 Modelled IHME
509,346 (410,966 - 631,589) 2000 Modelled IHME
523,345 (422,833 - 646,460) 2001 Modelled IHME
537,464 (433,146 - 664,240) 2002 Modelled IHME
551,660 (443,784 - 683,286) 2003 Modelled IHME
565,941 (454,770 - 702,022) 2004 Modelled IHME
580,313 (463,739 - 719,933) 2005 Modelled IHME
593,831 (474,405 - 740,215) 2006 Modelled IHME
606,214 (485,227 - 754,887) 2007 Modelled IHME
618,524 (496,141 - 771,239) 2008 Modelled IHME
631,842 (504,710 - 792,765) 2009 Modelled IHME
647,379 (517,628 - 815,871) 2010 Modelled IHME
664,858 (533,640 - 835,359) 2011 Modelled IHME
683,128 (550,467 - 857,693) 2012 Modelled IHME
702,208 (566,858 - 876,204) 2013 Modelled IHME
722,006 (584,718 - 902,225) 2014 Modelled IHME
742,375 (598,368 - 925,660) 2015 Modelled IHME
765,422 (617,947 - 953,915) 2016 Modelled IHME
789,783 (630,695 - 983,297) 2017 Modelled IHME
813,215 (648,932 - 1,015,680) 2018 Modelled IHME
837,035 (662,412 - 1,049,910) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.63 (3.78 - 7.84) 2019 Modelled IHME
5.6 (3.77 - 7.73) 2018 Modelled IHME
5.6 (3.82 - 7.61) 2017 Modelled IHME
5.57 (3.80 - 7.65) 2016 Modelled IHME
5.65 (3.85 - 7.70) 2015 Modelled IHME
5.74 (4 - 7.71) 2014 Modelled IHME
5.8 (4.15 - 7.78) 2013 Modelled IHME
5.81 (4.23 - 7.73) 2012 Modelled IHME
5.87 (4.34 - 7.65) 2011 Modelled IHME
6.07 (4.51 - 7.89) 2010 Modelled IHME
6.26 (4.70 - 8.11) 2009 Modelled IHME
6.44 (4.85 - 8.30) 2008 Modelled IHME
6.58 (4.93 - 8.45) 2007 Modelled IHME
6.68 (5.01 - 8.60) 2006 Modelled IHME
6.78 (5.04 - 8.73) 2005 Modelled IHME
6.8 (5.07 - 8.70) 2004 Modelled IHME
6.8 (5.08 - 8.78) 2003 Modelled IHME
6.78 (5.15 - 8.71) 2002 Modelled IHME
6.86 (5.25 - 8.77) 2001 Modelled IHME
6.75 (5.17 - 8.64) 2000 Modelled IHME
6.57 (5.05 - 8.47) 1999 Modelled IHME
6.26 (4.80 - 8.05) 1998 Modelled IHME
6.34 (4.76 - 8.13) 1997 Modelled IHME
6.39 (4.83 - 8.19) 1996 Modelled IHME
6.47 (4.85 - 8.36) 1995 Modelled IHME
6.57 (4.87 - 8.52) 1994 Modelled IHME
6.64 (4.96 - 8.62) 1993 Modelled IHME
6.7 (5.01 - 8.70) 1992 Modelled IHME
6.77 (5.08 - 8.76) 1991 Modelled IHME
6.85 (5.15 - 8.91) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,196 (2,145 - 4,449) 2019 Modelled IHME
3,093 (2,083 - 4,273) 2018 Modelled IHME
3,016 (2,055 - 4,099) 2017 Modelled IHME
2,925 (1,991 - 4,011) 2016 Modelled IHME
2,889 (1,969 - 3,933) 2015 Modelled IHME
2,855 (1,987 - 3,838) 2014 Modelled IHME
2,807 (2,007 - 3,768) 2013 Modelled IHME
2,740 (1,995 - 3,645) 2012 Modelled IHME
2,695 (1,990 - 3,510) 2011 Modelled IHME
2,712 (2,017 - 3,526) 2010 Modelled IHME
2,726 (2,044 - 3,530) 2009 Modelled IHME
2,730 (2,059 - 3,518) 2008 Modelled IHME
2,716 (2,038 - 3,491) 2007 Modelled IHME
2,688 (2,014 - 3,461) 2006 Modelled IHME
2,658 (1,974 - 3,423) 2005 Modelled IHME
2,598 (1,937 - 3,323) 2004 Modelled IHME
2,530 (1,890 - 3,265) 2003 Modelled IHME
2,456 (1,868 - 3,157) 2002 Modelled IHME
2,422 (1,852 - 3,093) 2001 Modelled IHME
2,319 (1,775 - 2,968) 2000 Modelled IHME
2,196 (1,689 - 2,830) 1999 Modelled IHME
2,038 (1,562 - 2,620) 1998 Modelled IHME
2,006 (1,507 - 2,571) 1997 Modelled IHME
1,967 (1,485 - 2,521) 1996 Modelled IHME
1,936 (1,452 - 2,501) 1995 Modelled IHME
1,910 (1,418 - 2,479) 1994 Modelled IHME
1,878 (1,402 - 2,436) 1993 Modelled IHME
1,839 (1,376 - 2,390) 1992 Modelled IHME
1,806 (1,354 - 2,336) 1991 Modelled IHME
1,775 (1,333 - 2,309) 1990 Modelled IHME
1,749 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
20 (14 - 27) 2019 Modelled IHME
20 (14 - 27) 2018 Modelled IHME
20 (14 - 27) 2017 Modelled IHME
19 (13 - 26) 2016 Modelled IHME
19 (13 - 26) 2015 Modelled IHME
19 (13 - 26) 2014 Modelled IHME
19 (13 - 26) 2013 Modelled IHME
19 (13 - 25) 2012 Modelled IHME
19 (13 - 25) 2011 Modelled IHME
19 (13 - 25) 2010 Modelled IHME
19 (13 - 25) 2009 Modelled IHME
19 (13 - 25) 2008 Modelled IHME
19 (13 - 25) 2007 Modelled IHME
19 (13 - 25) 2006 Modelled IHME
19 (13 - 25) 2005 Modelled IHME
19 (13 - 25) 2004 Modelled IHME
19 (13 - 25) 2003 Modelled IHME
19 (13 - 25) 2002 Modelled IHME
18 (13 - 25) 2001 Modelled IHME
18 (13 - 25) 2000 Modelled IHME
18 (13 - 25) 1999 Modelled IHME
18 (13 - 25) 1998 Modelled IHME
18 (13 - 25) 1997 Modelled IHME
18 (13 - 25) 1996 Modelled IHME
18 (13 - 25) 1995 Modelled IHME
18 (13 - 25) 1994 Modelled IHME
18 (13 - 24) 1993 Modelled IHME
18 (13 - 24) 1992 Modelled IHME
18 (13 - 24) 1991 Modelled IHME
18 (13 - 24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 3) 2016 Survey/reported Larney S et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
Year of HBV elimination goal
2030
HBV elimination goal
HBV testing policy
Pregnant women
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Hepatitis related deaths (national)

Modelled

HBV
1,602
2019
(1,027 - 2,303)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
3,196
2019
(2,145 - 4,449)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
2
2016
(1 - 3)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines